Thank you to our speakers, sponsors, guests and delegates who joined us in September for the summit! If you are interested in the 2024 event, please get in touch at info@hansonwade.com

The hotly anticipated 13^th World Clinical Biomarkers & CDx Summit returned as the only industry-led meeting uniting 500+ senior decision makers in the biomarker and CDx field to accelerate clinically validated and affordable co-development of drug-CDx by overcoming commercialization, reimbursement, and regulatory challenges in oncology and beyond to bring personalized medicine to patients faster.

Whether you are working in Oncology, NASH, or Neuroscience, join 600+ Directors, Heads, and VPs of Clinical Biomarkers, Translational Medicine, Precision Medicine & Companion Diagnostics together with drug and diagnostic developers, regulatory experts, payors and notified bodies for an exclusive opportunity of knowledge sharing and networking to propel your pipelines and make a marked difference for patient outcomes.